Jenny Johnson

Jenny Johnson is Chief Executive Officer of Franklin Templeton. In a career spanning over 35 years, she has been a key driver of the company's transformation to what is now one of the largest global investment managers across public and private asset classes with $1.6 trillion in assets under management.

Ms. Johnson held leadership roles in all major divisions of the business, including investment management, distribution, technology, operations and wealth management before becoming CEO in February 2020. She has led the evolution of the business in recent years, further diversifying the company's investment capabilities and solutions for clients through key strategic acquisitions and investments.

Ms. Johnson has been named to Forbes' “World's 100 Most Powerful Women” list for three consecutive years and has been included on Barron's list of the “100 Most Influential Women in US Finance” every year since the list’s inception in 2020. The Committee for Economic Development, the public policy center of The Conference Board, honored Ms. Johnson with a 2024 Distinguished Leadership Award.

Ms. Johnson serves on the board of directors of Thermo Fisher Scientific and the Investment Company Institute’s Board of Governors. She is a member of the International Advisory Panel of the Monetary Authority of Singapore and serves on the NYSE Board Advisory Council. In addition, Ms. Johnson is a board member of the Memorial Sloan Kettering Cancer Foundation and Catalyst. Previously, she served as a board member for Stanford’s Lucile Packard Children’s Hospital and the San Francisco Giants. Ms. Johnson earned her B.A. in economics from the University of California at Davis.